| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55,2 M € | +8.9% | 50,7 M € | +7.8% | 47,0 M € | -0.5% | 47,2 M € | -3.3% | 48,8 M € | +2.2% | 47,8 M € | +10.6% | 43,2 M € | +6.9% | 40,4 M € | -2.7% | 41,5 M € | +0.1% | 41,4 M € | +1.3% | 40,9 M € | +3.1% | 39,7 M € | +8.6% | 36,5 M € | +7.6% | 33,9 M € | +6.2% | 32,0 M € | +7.1% | 29,8 M € | +4.0% | 28,7 M € | -2.7% | 29,5 M € | +16.6% | 25,3 M € | |
| EBITDA | 1,8 M € | -57.8% | 4,3 M € | +301.0% | 1,1 M € | +702.7% | -177,5 k € | -104.1% | 4,3 M € | +124.5% | 1,9 M € | -29.1% | 2,7 M € | -2.7% | 2,8 M € | +9.8% | 2,5 M € | +62.5% | 1,6 M € | -51.0% | 3,2 M € | -13.0% | 3,6 M € | -0.9% | 3,7 M € | +5.3% | 3,5 M € | -32.5% | 5,2 M € | +9.1% | 4,7 M € | +41.2% | 3,4 M € | -27.6% | 4,6 M € | +24.2% | 3,7 M € | |
| Operating profit | -746,4 k € | -133.1% | 2,3 M € | +307.4% | -1,1 M € | +49.0% | -2,1 M € | -191.2% | 2,3 M € | +582.0% | 342,7 k € | -54.5% | 752,4 k € | -40.9% | 1,3 M € | +165.0% | 480,4 k € | +345.1% | -196,0 k € | -123.2% | 845,5 k € | -45.7% | 1,6 M € | +21.0% | 1,3 M € | +47.8% | 871,5 k € | -62.6% | 2,3 M € | +32.6% | 1,8 M € | +703.8% | 218,9 k € | -84.9% | 1,5 M € | +38.3% | 1,0 M € | |
| Profit/loss | -1,2 M € | -105.0% | 23,8 M € | +1159.8% | -2,2 M € | -289.3% | -575,7 k € | -148.2% | 1,2 M € | +40.7% | 848,3 k € | +3042.1% | 27,0 k € | -92.8% | 376,6 k € | +508.1% | 61,9 k € | -12.0% | 70,4 k € | -82.7% | 405,9 k € | -30.6% | 585,0 k € | +70.6% | 343,0 k € | +72.2% | 199,2 k € | -70.0% | 663,4 k € | -41.3% | 1,1 M € | +267.2% | -676,3 k € | -307.7% | 325,6 k € | -27.5% | 449,0 k € | |
| Equity | 31,9 M € | -3.6% | 33,1 M € | +239.8% | 9,7 M € | -18.7% | 12,0 M € | -6.5% | 12,8 M € | +10.3% | 11,6 M € | +7.9% | 10,8 M € | +0.3% | 10,7 M € | +3.6% | 10,4 M € | +0.6% | 10,3 M € | +0.7% | 10,2 M € | +0.2% | 10,2 M € | +2.1% | 10,0 M € | +0.3% | 10,0 M € | +0.2% | 10,0 M € | +0.7% | 9,9 M € | +5.5% | 9,4 M € | +23.5% | 7,6 M € | -0.7% | 7,6 M € | |
| Total assets | 63,2 M € | +1.2% | 62,4 M € | +16.3% | 53,7 M € | +3.7% | 51,8 M € | +3.9% | 49,8 M € | +4.5% | 47,7 M € | +5.3% | 45,3 M € | +7.7% | 42,1 M € | +3.5% | 40,7 M € | +3.6% | 39,2 M € | +10.4% | 35,5 M € | +6.1% | 33,5 M € | +8.1% | 31,0 M € | +6.2% | 29,2 M € | -7.0% | 31,4 M € | +0.1% | 31,3 M € | -3.8% | 32,6 M € | -6.6% | 34,9 M € | +0.5% | 34,7 M € | |
| Cash | 1,4 M € | -82.7% | 7,9 M € | +282.3% | 2,1 M € | +116.1% | 957,6 k € | -45.0% | 1,7 M € | +66.1% | 1,0 M € | +27.4% | 822,4 k € | -69.1% | 2,7 M € | +230.5% | 805,1 k € | -31.0% | 1,2 M € | -67.9% | 3,6 M € | +100.4% | 1,8 M € | +16.9% | 1,6 M € | +48.2% | 1,0 M € | +219.4% | 327,8 k € | -14.8% | 384,6 k € | -61.2% | 991,8 k € | +25.5% | 790,2 k € | +74.6% | 452,5 k € | |
| Debts | 30,6 M € | +6.8% | 28,7 M € | -34.2% | 43,6 M € | +10.4% | 39,5 M € | +7.1% | 36,9 M € | +2.3% | 36,0 M € | +4.5% | 34,5 M € | +10.7% | 31,1 M € | +3.3% | 30,1 M € | +6.2% | 28,4 M € | +13.4% | 25,0 M € | +9.0% | 23,0 M € | +11.2% | 20,6 M € | +8.2% | 19,1 M € | -10.4% | 21,3 M € | -0.1% | 21,3 M € | -7.2% | 23,0 M € | -15.6% | 27,2 M € | +0.7% | 27,0 M € | |
| Staff | 261,4 | 253,8 | 252,3 | 245,6 | 247,8 | 232,6 | 198,3 | 182,1 | 179,5 | 169,4 | 164,9 | 156,4 | 147,9 | 138,1 | 137,9 | 137,9 | 147 | 148,4 | 148,5 | |||||||||||||||||||
Public limited company · Hoogstraten · incorporated on 15/07/1941 · 261,4 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-82.7%).
Solid counterparty for a standard engagement.
KELA - Kempisch Laboratorium - Kela Laboratoria is a Public limited company incorporated in 1941. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Hoogstraten. It employs on average 261,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette